Quintela Inés, Eirís Jesús, Gómez-Lado Carmen, Pérez-Gay Laura, Dacruz David, Cruz Raquel, Castro-Gago Manuel, Míguez Luz, Carracedo Ángel, Barros Francisco
Grupo de Medicina Xenómica, Universidade de Santiago de Compostela, Centro Nacional de Genotipado - Plataforma de Recursos Biomoleculares y Bioinformáticos - Instituto de Salud Carlos III (CeGen-PRB2-ISCIII), Santiago de Compostela, Spain.
Complexo Hospitalario Universitario de Santiago de Compostela, Unidad de Neurología Pediátrica, Departamento de Pediatría, Santiago de Compostela, Spain.
Gene. 2017 Aug 30;626:189-199. doi: 10.1016/j.gene.2017.05.032. Epub 2017 May 12.
Intellectual disability (ID) is a complex and phenotypically heterogeneous neurodevelopmental disorder characterized by significant deficits in cognitive and adaptive skills, debuting during the developmental period. In the last decade, microarray-based copy number variation (CNV) analysis has been proved as a strategy particularly useful in the discovery of loci and candidate genes associated with these phenotypes and is widely used in the clinics with a diagnostic purpose. In this study, we evaluated the usefulness of two genome-wide high density SNP microarrays -Cytogenetics Whole-Genome 2.7M SNP array (n=126 patients; Group 1) and CytoScan High-Density SNP array (n=447 patients; Group 2)- in the detection of clinically relevant CNVs in a cohort of ID patients from Galicia (NW Spain). In 159 (27.7%) patients, we detected 186 rare exonic chromosomal imbalances, that were grouped into the following classes: Clinically relevant (67/186; 36.0%), of unknown clinical significance (93/186; 50.0%) and benign (26/186; 14.0%). The 67 pathogenic CNVs were identified in 64 patients, which means an overall diagnostic yield of 11.2%. Overall, we confirmed that ID is a genetically heterogeneous condition and emphasized the importance of using genome-wide high density SNP microarrays in the detection of its genetic causes. Additionally, we provided clinical and molecular data of patients with pathogenic or likely pathogenic CNVs and discussed the potential implication in neurodevelopmental disorders of genes located within these variants.
智力残疾(ID)是一种复杂的、表型异质性的神经发育障碍,其特征是认知和适应技能存在显著缺陷,在发育期间首次出现。在过去十年中,基于微阵列的拷贝数变异(CNV)分析已被证明是一种特别有助于发现与这些表型相关的基因座和候选基因的策略,并在临床上广泛用于诊断目的。在本研究中,我们评估了两种全基因组高密度单核苷酸多态性(SNP)微阵列——细胞遗传学全基因组270万个SNP阵列(n = 126例患者;第1组)和CytoScan高密度SNP阵列(n = 447例患者;第2组)——在检测来自西班牙西北部加利西亚的一组ID患者中临床相关CNV方面的实用性。在159例(27.7%)患者中,我们检测到186个罕见的外显子染色体不平衡,这些不平衡被分为以下几类:临床相关(67/186;36.0%)、临床意义不明(93/186;50.0%)和良性(26/186;14.0%)。在64例患者中鉴定出67个致病性CNV,这意味着总体诊断率为11.2%。总体而言,我们证实ID是一种遗传异质性疾病,并强调了使用全基因组高密度SNP微阵列检测其遗传原因的重要性。此外,我们提供了致病性或可能致病性CNV患者的临床和分子数据,并讨论了这些变异内基因在神经发育障碍中的潜在影响。